摘要
目的探讨头孢呋辛钠联合氨溴索治疗老年慢性支气管炎急性发作的临床疗效。方法 126例老年慢性支气管炎急性发作患者随机均分为治疗组和对照组。两组均予静脉滴注头孢呋辛钠,1.5g/次,2次/d;治疗组加用静脉滴注氨溴索30mg/次,2次/d,疗程为7d。结果治疗组和对照组有效率分别为93.65%和80.95%(P<0.05),痊愈率分别为77.78%和58.73%(P<0.01)。结论头孢呋辛钠联氨溴索治疗老年慢性支气管炎急性发作的临床疗效好、安全性好、无明显不良反应。
Objective To investigate the efficacy of cefuroxime conbined with ambroxol in treating acute exacerbation of chronic bronchitis. Methods 126 patients were randomly divided into the treatment group and control group. Both groups were treated with intra venous cefuroxime 1.5 g/times, 2 times/d; the treatment group received intravenous infusion hydrochloride amhroxol injection of 30 mg/times, 2 times/d, treatment for 7 d. Results The effective rates of the treatment group and the control group were 93.65% and 80.95%, respectively （P 〈0.05）, the curative rates were 77.78% and 58.73% （P 〈0.01）. Conclusions Cefuroxime and ambroxol are of clinical efficacy and safety in the treatment of elderly patients with acute exacerbation of chronic bronchitis, without significant adverse reactions.
出处
《临床医学工程》
2012年第12期2190-2191,共2页
Clinical Medicine & Engineering
